Gator, I have been thinking the same thing, no way would they let Biogen grab the CNS market without a fight. They are loaded to the celling with cash, and are on the hunt for acquisitions.
Pfizer has a ton of Covid vaccine cash. I could see it making an offer too good to reject if either the Alzheimer’s or Parkinson’s data is positive.